3hon MSN
Discovery of viral entry routes and decoy molecules could block yellow fever and encephalitis
Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
17hon MSN
Naked Mole Rats: The tiny creatures unlocking the future of cancer treatment and fertility control
Unlocking secrets from East Africa's naked mole rats, scientists are amazed by their cancer immunity and unique social ...
The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted ...
The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...
Constative on MSN
The Oddest Animals Born From Human Design
Humans have long experimented with nature, bending evolution to serve aesthetics, science, and curiosity. Some animals have ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
Researchers at Flinders University have discovered that dopamine not only helps us learn but also plays a critical role in ...
Allied Market Research published a report, titled, 'Cystic Fibrosis (CF) Therapeutics Market - Global Opportunity Analysis ...
The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results